Edition:
United Kingdom

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

7.35USD
19 Apr 2018
Change (% chg)

$-0.21 (-2.78%)
Prev Close
$7.56
Open
$7.51
Day's High
$7.60
Day's Low
$7.15
Volume
426,080
Avg. Vol
265,466
52-wk High
$12.20
52-wk Low
$2.14

Chart for

About

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System... (more)

Overall

Beta: 0.35
Market Cap(Mil.): $41.19
Shares Outstanding(Mil.): 50.23
Dividend: --
Yield (%): --

Financials

  TNDM.OQ Industry Sector
P/E (TTM): -- 32.19 32.74
EPS (TTM): -2.64 -- --
ROI: -120.44 13.89 14.38
ROE: -1,308.23 16.72 16.07

BRIEF-Tandem Diabetes Care Q1 Sales $27 Mln Vs I/B/E/S View $25 Mln

* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY FIRST QUARTER 2018 RESULTS

10 Apr 2018

BRIEF-Tandem Diabetes Care And Movi SpA Announce Agreement For Distribution Of Insulin Pump Products In Italy

* TANDEM DIABETES CARE AND MOVI SPA ANNOUNCE AGREEMENT FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN ITALY

09 Apr 2018

BRIEF-Tandem Diabetes Care Q4 Sales $40.3 Million

* ‍SALES FOR Q1 OF 2018 ARE ESTIMATED TO BE 18 PERCENT - 19 PERCENT OF ANNUAL SALES​

01 Mar 2018

BRIEF-Tandem Diabetes Care Applies For Health Canada Medical Device License

* TANDEM DIABETES CARE APPLIES FOR HEALTH CANADA MEDICAL DEVICE LICENSE

20 Feb 2018

BRIEF-Tandem Diabetes Care Files For Offering Of 13.5 Mln Shares Of Co's Common Stock

* TANDEM DIABETES CARE FILES FOR OFFERING OF 13.5 MILLION SHARES OF CO'S COMMON STOCK, PAR VALUE $0.001 PER SHARE - SEC FILING‍​‍​ Source text: (http://bit.ly/2nmA5Fh) Further company coverage:

29 Jan 2018

BRIEF-Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln

* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE

09 Jan 2018

BRIEF-Tandem Diabetes Care Says May Offer Combination Of Stock Not Exceeding $10.7 Mln

* TANDEM DIABETES CARE SAYS MAY OFFER COMBINATION OF STOCK, PREFERRED STOCK, WARRANTS OR UNITS HAVING INITIAL OFFERING PRICE NOT EXCEEDING $10.7 MILLION Source text: (http://bit.ly/2oGBPwa) Further company coverage:

18 Dec 2017

BRIEF-Tandem Diabetes Care reports Q3 sales of $27 million

* Tandem Diabetes Care reports third quarter 2017 financial results

26 Oct 2017

BRIEF-‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost

* ‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​

24 Oct 2017

BRIEF-Empery Asset Management reports 5.63 pct passive stake in Tandem Diabetes Care

* Empery Asset Management Lp reports 5.63 pct passive stake in Tandem Diabetes Care Inc as of Oct 13 - SEC filing‍​ Source text: (http://bit.ly/2hSFBfg) Further company coverage:

20 Oct 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $127.55 -0.17
Roche Holding Ltd. (ROG.S) CHF216.40 -0.10
Roche Holding Ltd. (RO.S) CHF219.80 -0.40
Insulet Corporation (PODD.OQ) $88.45 -0.19

Earnings vs. Estimates